T3 Pharmaceuticals AG news
T3 Pharmaceuticals AG – a biotech company focused on immuno-oncology – wins the SEF award 2021 in the category High-tech/Biotech.
In a multi-step selection process and among 107 applicants the distinguished jury has bestowed T3 Pharma with the SEF award 2021. «We are honored to receive such a prestigious price from the Swiss Economic Forum», commented Simon Ittig, CEO of T3 Pharma. «We would like to thank the jury for
T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based protein delivery platform, today announced the closing of its third financing round, raising over 25M CHF.
The financing was co-led by existing investors, including the Boehringer Ingelheim Venture Fund (BIVF), Reference Capital SA, Wille Finance AG and private investors, who all participated in the round. This latest financing brings T3 Pharma’s to
T3 Pharmaceuticals AG (T3), a Basel (Switzerland)-based company focusing on immuno-oncology, closes its second financing round of over 12M CHF with existing investors joined by «Boehringer Ingelheim Venture Fund» (BIVF) and «Reference Capital SA». To progress into the clinical phase, T3 appoints Claire Barton as Chief Medical Officer, strengthens its development team and announces the clinical advisory board.
«We are very pleased to be jo
T3 Pharmaceuticals AG – a biotech company in Basel focused on immunooncology – wins the W.A. de Vigier Foundation’s highest endowed award for startup companies in Switzerland with CHF 100,000 in prize money.
«We are honored to receive the W.A. de Vigier Foundation’s oldest and highest endowed sponsorship award and would like to thank the foundation and foundation board for recognizing the potential of our immuno-oncology approach. Our tha
T3 Pharmaceuticals (“T3 Pharma”), a biotech company with a focus on immuno-oncology, today announced it has been named “2018 Science Start-Up of the Year” by Falling Walls Venture. The award honors emerging scientist-entrepreneurs for their breakthrough business models.
The Falling Walls Conference in Berlin, Germany, annually invites the world’s leading scientists to identify trends, opportunities and solutions for global challe